In endometrial hyperplasia and endometrial cancer, the expression of insulin receptors A and B (IR-A and IR-B) and type-1 insulin like growth factor receptor (IGF-1R) is upregulated compared to normal endometrium (48). Here, IGF1R is linked to endometrial cancer.